GENE ONLINE|News &
Opinion
Blog

IPO
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
Exploring AI’s Impact on Biotech Breakthroughs and International Funding
2023-08-29
GeneOnline’s Weekly News Highlights: July 10-14
2023-07-17
A Multi-Billion Budding Venture in Consumer Health, J&J’s Kenvue Aims to Raise $3.5 Billion in IPO
2023-04-27
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
Biotech Showcase 2022: The China Factor
2022-01-24
APAC CRO Novotech Mulls IPO after $255 Million Round
2022-01-20
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top